DOSTÁLOVÁ, Lenka, Aneta LEDEREROVÁ, Helena PESCHELOVÁ, Tomáš LOJA and Michal ŠMÍDA. Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation in rituximab-resistant cells. In PhD and PostDoc RETREAT, Sněžné, Milovy. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation in rituximab-resistant cells.
Authors DOSTÁLOVÁ, Lenka, Aneta LEDEREROVÁ, Helena PESCHELOVÁ, Tomáš LOJA and Michal ŠMÍDA.
Edition PhD and PostDoc RETREAT, Sněžné, Milovy, 2023.
Other information
Original language English
Type of outcome Konferenční abstrakta
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Organization Středoevropský technologický institut – Repository – Repository
Keywords in English CD20 antigen; therapy of B-cell malignancies; antiCD20 mAb; CRISPR/Cas9 knockout screening;
Links LX22NPO5102, research and development project.
Changed by Changed by: RNDr. Daniel Jakubík, učo 139797. Changed: 3/4/2024 04:19.
Abstract
CD20 antigen has been used as a target of monoclonal antibodies (mAb) such as rituximab (RTX) in the therapy of B-cell malignancies for more than two decades. However, malignant B cells downregulate CD20 on their surface, resulting in mAb resistance and therapy failure. Therefore, it is crucial to investigate the CD20 regulation to enhance the efficacy of antiCD20 mAb. This project aimed to perform CRISPR/Cas9 knockout screening to identify genes whose disruption restores CD20 surface expression. To create a model mimicking the situation in patients who have developed resistance to mAb therapy, we generated RTX-resistant CD20-low B-cell line by chronic exposure to rituximab. These cells were transduced by the GeCKO lentiviral library to obtain a collection of single-gene knockouts. After 2.5-week cultivation, the top 5% of cells with the highest expression of CD20 were sorted out. Using next-generation sequencing, we identified gene knockouts responsible for CD20 upregulation. CRISPR/Cas9 screening revealed several genes whose disruption increased CD20 surface expression. CSK, encoding a negative regulator of Src kinases, as well as PTEN, a well-known tumor suppressor, were among the top hits. These two genes are involved in the B-cell receptor (BCR) pathway – an essential pathway in B cells. Interestingly, we identified four genes SSR1- 4, encoding all four subunits of the TRAP complex, an endoplasmic reticular complex involved in protein translocation across ER membrane. STT3A, encoding the catalytic subunit of oligosaccharyltransferase, was another ER-associated gene revealed by the screening. These results indicate that both BCR signalling and ER play an important role in CD20 regulation. Selected genes were validated, and the mechanism of their function is being investigated. The understanding of underlying mechanisms could provide a way for a potential enhancement of anti-CD20 mAb therapy.
Print
Add to clipboard Displayed: 12/7/2024 00:25